How Often Should You Have The Shingles Vaccine?

Most adults need the shingles vaccine once, given as two shots two to six months apart. That is true whether or not you have had shingles before and whether or not you had the older shingles vaccine in the past. Current guidance does not call for routine booster doses later in life. The details below explain who this applies to, why the schedule changed, and where genuine uncertainty still exists.

How Often Should You Have The Shingles Vaccine?

The short answer is once, in two doses. The Centers for Disease Control and Prevention recommends the recombinant zoster vaccine (sold as Shingrix) for adults aged 50 and older, given as two injections separated by two to six months. There is no recommended periodic booster after that series.

This is a change from how the earlier vaccine worked. The older live vaccine (Zostavax) was given as a single dose and was not routinely repeated. The recombinant vaccine replaced it in US recommendations, and the two-dose series is now the standard.

One point people often miss: the two doses are not a “first shot now, booster in ten years” arrangement. They are a single series. Both doses are needed to complete the schedule. Skipping the second dose leaves the protection incomplete.

Why Is the Shingles Vaccine Given Only Once?

Shingles is caused by the varicella-zoster virus, the same virus that causes chickenpox. After you recover from chickenpox, the virus does not leave your body. It settles into nerve tissue and stays dormant for decades. Shingles happens when that dormant virus reactivates and travels along a nerve to the skin.

The vaccine works by training your immune system to recognize and suppress the virus if it reactivates. The two-dose series produces a strong immune response that appears to hold for years. Current recommendations reflect the evidence that this response remains meaningful over time, so a routine booster is not advised.

That does not mean protection is permanent or identical for everyone. Immune protection tends to decline with age and with certain medical conditions. Researchers continue to track how long protection lasts and whether a booster will eventually be recommended. As of now, no booster is part of the standard schedule.

The vaccine is not a treatment for shingles. It is given to people who do not currently have an active rash. If you have shingles now, the vaccine is not used to shorten that episode.

What If You Miss the Second Dose?

If more than six months have passed since your first dose, you do not need to start over. You simply get the second dose as soon as you can. The series does not restart.

The two-to-six-month window is the recommended spacing. Some clinicians use a shorter interval of one to two months for people who are immunocompromised, because the timing guidance differs for that group. If you are unsure which interval applies to you, ask your clinician rather than guessing.

Getting the second dose matters. The series is designed to be completed, and partial protection is not the same as the full two-dose response. If you received the first dose and life got in the way, it is not too late to finish.

Who Should Get the Shingles Vaccine?

Adults aged 50 and older are the core group. The recommendation applies regardless of whether you remember having chickenpox. Many people were exposed without knowing it, and the virus can be present even without a clear history of chickenpox.

Adults aged 19 and older who are immunocompromised are also recommended to receive the vaccine, according to CDC guidance. This includes people with certain cancers, those receiving immunosuppressive treatment, transplant recipients, and people with HIV. The timing and interval can differ in this group, so this is a conversation to have with the treating clinician.

The vaccine is also recommended for people who have already had shingles. Having shingles once does not prevent it from happening again, and the vaccine can help reduce the risk of future episodes.

People who received the older live vaccine in the past are generally recommended to get the recombinant vaccine as well, because the two are not interchangeable and the recombinant vaccine is the current standard.

Who Should Not Get It, and What About Side Effects?

The recombinant vaccine is not a live vaccine, which means it does not contain a weakened form of the virus that could cause infection. That is one reason it can be used in people with weakened immune systems, unlike the older live vaccine.

You should not get the vaccine if you have had a severe allergic reaction to a previous dose or to any component of the vaccine. If you currently have shingles or another acute illness, vaccination is typically postponed until you recover. People who are pregnant should discuss timing with their clinician; the available evidence on use during pregnancy is limited, and this is a case where you should follow your clinician’s guidance rather than assume.

Side effects are common and usually short-lived. The most frequent are soreness at the injection site, fatigue, muscle aches, headache, and fever. These reactions tend to be more noticeable than with many other adult vaccines, and they are a sign the immune system is responding. They generally resolve within a few days.

Serious adverse events are rare. As with any vaccine, there is a small risk of a severe allergic reaction, which is why vaccination is given in settings equipped to manage it.

How Well Does It Work?

The vaccine reduces the risk of shingles and, importantly, the risk of postherpetic neuralgia — the lingering nerve pain that can follow a shingles rash and is one of the most feared complications. Reducing that complication is a major part of why the vaccine matters, especially for older adults.

Protection is not absolute. Some vaccinated people still develop shingles, but the vaccine is designed to make that less likely and to reduce the severity and complications when it does occur. Effectiveness is generally described as high in clinical trials, and it appears to decline somewhat with age and over time. The exact degree of waning is still being studied, which is part of why booster recommendations could change in the future.

It is worth being clear about what the evidence does and does not show. The vaccine is well studied and recommended by public health authorities. What remains an open question is the long-term picture — how much protection remains a decade or more after vaccination, and whether a booster will eventually be advised. Anyone who tells you the answer is settled is getting ahead of the data.

Common Misconceptions About the Schedule

A few ideas circulate that are worth correcting.

• “I need a booster every year like a flu shot.” No. The shingles vaccine is a two-dose series, not an annual shot. No routine booster is currently recommended.
• “I had shingles, so I don’t need it.” You can get shingles more than once. The vaccine is still recommended after a previous episode.
• “I had the old shingles shot, so I’m covered.” The current standard is the recombinant vaccine. People who received the older vaccine are generally advised to get the current one.
• “The vaccine gives you shingles.” The recombinant vaccine is not live, so it cannot cause shingles. The older live vaccine also did not cause shingles in the way people fear, but it is no longer the standard in the US.

One clarification that surprises people: the shingles vaccine does not prevent chickenpox, and it is not a substitute for chickenpox vaccination in children. They are related viruses but different schedules for different purposes.

What to Do If You Are Unsure

Guidance can change as new evidence emerges, and the shingles vaccine schedule is no exception. If you are immunocompromised, pregnant, or managing a complex medical condition, the general schedule may not fit your situation exactly. Those are the cases where a clinician who knows your history should weigh in.

For most healthy adults aged 50 and older, the answer is straightforward: two doses, two to six months apart, and no routine booster afterward. If you have not started the series, the first step is a conversation with your clinician or pharmacist about timing and what to expect.